Skip to main content Accessibility help
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2011
  • Online publication date: August 2011

3 - Epilepsy beginning in middle childhood


1. Stephenson J, Whitehouse WP, Zuberi S. Paroxysmal nonepileptic disorders: differential diagnosis of epilepsy. In: Wallace SJ, Farrell K, eds. Epilepsy in Children 2nd edn. London, Arnold. 2004; 4–20.
2. Eldridge PR, Punt JA. Risks associated with giving benzodiazepines to patients with acute neurological injuries. BMJ 1990; 300: 1189–90.
3. American Academy of Pediatrics: The neurodiagnostic evaluation of the child with a first simple febrile seizure. Pediatrics 1996; 97: 769–72.
4. Allen JE, Ferrie CD, Livingston JH, Feltbower RG. Recovery of consciousness after epileptic seizures in children. Arch Dis Child 2007; 92: 39–42.
5. Lempert T, Bauer M, Schmidt D. Syncope: a videometric analysis of 56 episodes of transient cerebral hypoxia. Ann Neurol 1994; 36: 233–7.
6. Horrocks IA, Nechay A, Stephenson JB, Zuberi SM. Anoxic–epileptic seizures: observational study of epileptic seizures induced by syncopes. Arch Dis Child 2005; 90: 1283–7.
7. Revised terminology and concepts for organization of the epilepsies: Report of the Commission on Classification and Terminology 2009:
8. Panayiotopoulos CP. Typical absence seizures and related epileptic syndromes: assessment of current state and directions for future research. Epilepsia 2008; 49: 2131–9.
9. Marini C, Harkin LA, Wallace RH, et al. Childhood absence epilepsy and febrile seizures: a family with a GABA(A) receptor mutation. Brain 2003; 126: 230–40.
10. Lillywhite LM, Saling MM, Harvey AS, et al. Neuropsychological and functional MRI studies provide converging evidence of anterior language dysfunction in BECTS. Epilepsia 2009; 50: 2276–84.
11. Ferrie C, Caraballo R, Covanis A, et al. Panayiotopoulos syndrome: a consensus view. Dev Med Child Neurol 2006; 48: 236–40.
12. Caraballo R, Cers´osimo R, Fejerman N. Panayiotopoulos syndrome: a prospective study of 192 patients. Epilepsia 2007; 48: 1054–61.
13. Guerrini R, Parmeggiani L, Bonanni P, et al. Myoclonic astatic epilepsy. In: Roger J, Bureau M, Dravet C, et al., eds. Epileptic Syndromes in Infancy, Childhood and Adolescence. Paris, John Libbey 2005; 115–24.
14. Livingston JH. Management of epilepsies associated with specific diseases in children. In: Shorvon S, Perucca E, Engel J, eds. The Treatment of Epilepsy 3rd edn. Oxford, Wiley–Blackwell 2009; 195–202.
15. Gaillard WD, Chiron C, Cross JH, et al. Guidelines for imaging infants and children with recent-onset epilepsy. Epilepsia 2009; 50: 2147–53.
16. Cramer JA, Glassman M, Rienzi V. The relationship between poor medication compliance and seizures. Epilepsy Behav 2002; 3: 338–42.
17. Dudley RW, Penney SJ, Buckley DJ. First-drug treatment failures in children newly diagnosed with epilepsy. Pediatr Neurol 2009; 40: 71–7.
18. Carpay HA, et al. Epilepsy in childhood: an audit of clinical practice. Arch Neurol 1998; 55: 668–73.
19. Camfield CS, Camfield PR, Veugelers PJ. Death in children with epilepsy: a population-based study. Lancet 2002; 359: 1891–5.
20. Sillanpaa M, et al. Long-term prognosis of seizures with onset in childhood. N Engl J Med 1998; 338: 1715–22.
21. Berg AT, et al. Mortality in childhood-onset epilepsy. Arch Pediatr Adolesc Med 2004; 158: 1147–52.
22. Callenbach PM, et al. Mortality risk in children with epilepsy: the Dutch study of epilepsy in childhood. Pediatrics 2001; 107: 1259–63.
23. Diekema DS, Quan L, Holt VL. Epilepsy as a risk factor for submersion injury in children. Pediatrics 1993; 91: 612–6.
24. Kemp AM, Sibert JR. Epilepsy in children and the risk of drowning. Arch Dis Child 1993; 68: 684–5.
25. Deekollu D, Besag FM, Aylett SE. Seizure-related injuries in a group of young people with epilepsy wearing protective helmets: incidence, types and circumstances. Seizure 2005; 14: 347–53.
26. Samaniego EA, Sheth RD. Bone consequences of epilepsy and antiepileptic medications. Semin Pediatr Neurol 2007; 14: 196–200.
27. Wirrell EC, et al. Accidental injury is a serious risk in children with typical absence epilepsy. Arch Neurol 1996; 53: 929–32.
28. Appleton RE. The Mersey Region Pediatric Epilepsy Interest Group. Seizure-related injuries in children with newly diagnosed and untreated epilepsy. Epilepsia 2002; 43: 764–7.
29. Carpay HA, et al. Disability due to restrictions in childhood epilepsy. Dev Med Child Neurol 1997; 39: 521–6.
30. Wirrell EC, et al. Long-term psychosocial outcome in typical absence epilepsy. Sometimes a wolf in sheep's clothing. Arch Pediatr Adolesc Med 1997; 151: 152–8.
31. Camfield C, et al. Biologic factors as predictors of social outcome of epilepsy in intellectually normal children: a population-based study. J Pediatr 1993; 122: 869–73.
32. Jalava M, et al. Social adjustment and competence 35 years after onset of childhood epilepsy: a prospective controlled study. Epilepsia 1997; 38: 708–15.
33. Sillanpaa M. Epilepsy in children: prevalence, disability, and handicap. Epilepsia 1992; 33: 444–9.
34. Nolan MA, et al. Intelligence in childhood epilepsy syndromes. Epilepsy Res 2003; 53: 139–50.
35. Hermann BP, et al. Cognitive and magnetic resonance volumetric abnormalities in new-onset pediatric epilepsy. Semin Pediatr Neurol 2007; 14: 173–80.
36. Seidenberg M, Pulsipher DT, Hermann B. Cognitive progression in epilepsy. Neuropsychol Rev 2007; 17: 445–54.
37. Hermann BP, et al. Growing up with epilepsy: A two-year investigation of cognitive development in children with new onset epilepsy. Epilepsia 2008; 49: 1847–58.
38. Dunn DW, et al. ADHD and epilepsy in childhood. Dev Med Child Neurol 2003; 45: 50–4.
39. Hermann B, et al. The frequency, complications and etiology of ADHD in new onset pediatric epilepsy. Brain 2007; 130: 3135–48.
40. Austin JK, et al. Behavior problems in children before first recognized seizures. Pediatrics 2001; 107: 115–22.
41. Austin JK, Dunn DW. Progressive behavioral changes in children with epilepsy. Prog Brain Res 2002; 135: 419–27.
42. Sherman EM, et al. ADHD, neurological correlates and health-related quality of life in severe pediatric epilepsy. Epilepsia 2007; 48: 1083–91.
43. Baptista-Neto L, et al. An expert opinion on methylphenidate treatment for attention deficit hyperactivity disorder in pediatric patients with epilepsy. Expert Opin Investig Drugs 2008; 17: 77–84.
44. Rutter M, Yule GPW. A neuropsychiatric study in childhood. Philadelphia, Lippincott 1970.
45. Jones JE, et al. Psychiatric comorbidity in children with new onset epilepsy. Dev Med Child Neurol 2007; 49: 493–7.
46. Ettinger AB, et al. Symptoms of depression and anxiety in pediatric epilepsy patients. Epilepsia 1998; 39: 595–9.
47. Jones JE, et al. Psychiatric disorders in children and adolescents who have epilepsy. Pediatr Rev 2008; 29: e9–14.
48. Wirrell E, et al. Sleep disturbances in children with epilepsy compared with their nearest-aged siblings. Dev Med Child Neurol 2005; 47: 754–9.
49. Stores G, Wiggs L, Campling G. Sleep disorders and their relationship to psychological disturbance in children with epilepsy. Child Care Health Dev 1998; 24: 5–19.
50. Koh S, et al. Sleep apnea treatment improves seizure-control in children with neuro-developmental disorders. Pediatr Neurol 2000; 22: 36–9.
51. Ghazziuddin M. Seizure disorder in autism spectrum disorders: an overview. In: Riva D, Rapin I, eds. Autistic Spectrum Disorders. Montrouge, John Libbey Eurotext 2005; 69–74.
52. Camfield PR, et al. If a first antiepileptic drug fails to control a child's epilepsy, what are the chances of success with the next drug? J Pediatr 1997; 131: 821–4.
53. Dudley RW, Penny SJ, Buckley DJ. First-drug treatment failures in children newly diagnosed with epilepsy. Pediatr Neurol 2009; 40: 71–7.
54. Uldall P, et al. The misdiagnosis of epilepsy in children admitted to a tertiary epilepsy centre with paroxysmal events. Arch Dis Child 2006; 91: 219–21.
55. Snead OC, 3rd, Hosey LC. Exacerbation of seizures in children by carbamazepine. N Engl J Med 1985; 313: 916–21.
56. Talwar D, Arora MS, Sher PK. EEG changes and seizure exacerbation in young children treated with carbamazepine. Epilepsia 1994; 35: 1154–9.
57. Kochen S, Giagante B, Oddo S. Spike-and-wave complexes and seizure exacerbation caused by carbamazepine. Eur J Neurol 2002; 9: 41–7.
58. Corda D, et al. Incidence of drug-induced aggravation in benign epilepsy with centrotemporal spikes. Epilepsia 2001; 42: 754–9.
59. Lortie A, et al. The potential for increasing seizure frequency, relapse, and appearance of new seizure types with vigabatrin. Neurology 1993; 43(Suppl 5): S24–7.
60. Tassinari CA, et al. Tonic status epilepticus precipitated by intravenous benzodiazepine in five patients with Lennox-Gastaut syndrome. Epilepsia 1972; 13: 421–35.
61. Wheless JW, et al. Treatment of pediatric epilepsy: European expert opinion, 2007. Epileptic Disord 2007; 9: 353–412.
62. Wheless JW, Clarke DF, Carpenter D. Treatment of pediatric epilepsy: expert opinion, 2005. J Child Neurol 2005; 20(Suppl 1): S1–56; quiz S59–60.
63. Glauser TA, Cnaan A, Shinnar S, et al. Ethosuximide, valproic acid and lamotrigine in childhood absence epilepsy. New Eng J Med 2010; 362: 790–9.
64. Glauser T, Kluger G, Sachdeo R, Krauss G, Perdorno C, Arroyo S. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology 2008; 70: 1950–8.
65. Hancock E, Cross H. Treatment of Lennox-Gastaut syndrome. Cochrane Database Syst Rev 2003; 3: CD003277.
66. Neal EG, Chaffe H, Schwartz RH, et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurology 2008; 122: 334–40.
67. Freeman JM, Vining EP, Kossoff EH, Pyzik PL, Ye X, Goodman SN. A blinded, crossover study of the efficacy of the ketogenic diet. Epilepsia 2009; 50: 322–5.
68. Rating D, Wolf C, Bast T. Sulthiame as monotherapy in children with benign childhood epilepsy with centrotemporal spikes: a 6-month randomized, double-blind, placebo-controlled study. Sulthiame Study Group. Epilepsia 2000; 41: 1284–8.
69. Sirven JI, Sperling M, Wingerchuk DM. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission. Cochrane Database Syst Rev 2001; 3: CD001902.
70. Peters AC, et al. Randomized prospective study of early discontinuation of antiepileptic drugs in children with epilepsy. Neurology 1998; 50: 724–30.
71. Bouma PA, et al. The course of benign partial epilepsy of childhood with centrotemporal spikes: a meta-analysis. Neurology 1997; 48: 430–7.
72. Camfield P, Camfield C. The frequency of intractable seizures after stopping AEDs in seizure-free children with epilepsy. Neurology 2005; 64: 973–5.
73. Ranganathan LN, Ramaratnam S. Rapid versus slow withdrawal of antiepileptic drugs. Cochrane Database Syst Rev 2006; 2: CD005003.
74. Berg AT, et al. Early development of intractable epilepsy in children: a prospective study. Neurology 2001; 56: 1445–52.
75. Carpay HA, et al. Epilepsy in childhood: an audit of clinical practice. Arch Neurol 1998; 55: 668–73.
76. Elkis LC, et al. Efficacy of second antiepileptic drug after failure of one drug in children with partial epilepsy. Epilepsia 1993; 34(Suppl 6): 107 (Abstract).
77. Aso K, Watanabe K. Limitations in the medical treatment of cryptogenic or symptomatic localization-related epilepsies of childhood onset. Epilepsia 2000; 41(Suppl 9): 18–20.
78. Spencer S, Huh L. Outcomes of epilepsy surgery in adults and children. Lancet Neurol 2008; 7: 525–37.
79. Murphy JV. Left vagal nerve stimulation in children with medically refractory epilepsy. The Pediatric VNS Study Group. J Pediatr 1999; 134: 563–6.
80. Buoni S, et al. Vagus nerve stimulation for drug resistant epilepsy in children and young adults. Brain Dev 2004; 26: 158–63.
81. Benifla M, et al. Vagal nerve stimulation for refractory epilepsy in children: indications and experience at The Hospital for Sick Children. Childs Nerv Syst 2006; 22: 1018–26.
82. Parker AP, et al. Vagal nerve stimulation in epileptic encephalopathies. Pediatrics 1999; 103: 778–82.
83. Kossoff EH, et al. Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia 2009; 50: 304–17.
84. Neal EG, et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol 2008; 7: 500–6.
85. Snead OC, 3rd, Benton JW, Myers GJ. ACTH and prednisone in childhood seizure disorders. Neurology 1983; 33: 966–70.
86. Gupta R, Appleton R. Corticosteroids in the management of the paediatric epilepsies. Arch Dis Child 2005; 90: 379–84.
87. Tsuru T, et al. Effects of high-dose intravenous corticosteroid therapy in Landau–Kleffner syndrome. Pediatr Neurol 2000; 22: 145–7.
88. Hart YM, et al. Medical treatment of Rasmussen's syndrome (chronic encephalitis and epilepsy): effect of high-dose steroids or immunoglobulins in 19 patients. Neurology 1994; 44: 1030–6.
89. Mikati MA, et al. Efficacy of intravenous immunoglobulin in Landau–Kleffner syndrome. Pediatr Neurol 2002; 26: 298–300.
90. Illum N, et al. Intravenous immunoglobulin: a single-blind trial in children with Lennox-Gastaut syndrome. Neuropediatrics 1990; 21: 87–90.
91. Camfield C, et al. Outcome of childhood epilepsy: a population-based study with a simple predictive scoring system for those treated with medication. J Pediatr 1993; 122: 861–8.
92. Sillanpaa M, Camfield P, Camfield C. Predicting long-term outcome of childhood epilepsy in Nova Scotia, Canada, and Turku, Finland. Validation of a simple scoring system. Arch Neurol 1995; 52: 589–92.
93. Wirrell EC, et al. Long-term prognosis of typical childhood absence epilepsy: remission or progression to juvenile myoclonic epilepsy. Neurology 1996; 47: 912–8.
94. Camfield P, Camfield C. Long-term prognosis for symptomatic (secondarily) generalized epilepsies: a population-based study. Epilepsia 2007; 48: 1128–32.
95. Camfield CS, Camfield PR. Long-term social outcomes for children with epilepsy. Epilepsia 2007; 48(Suppl 9): 3–5.
96. Baglietto MG, et al. Neuropsychological disorders related to interictal epileptic discharges during sleep in benign epilepsy of childhood with centrotemporal or Rolandic spikes. Dev Med Child Neurol 2001; 43: 407–12.
97. Deonna T, et al. Benign partial epilepsy of childhood: a longitudinal neuropsychological and EEG study of cognitive function. Dev Med Child Neurol 2000; 42: 595–603.
98. Hernandez MT, et al. Attention, memory, and behavioral adjustment in children with frontal lobe epilepsy. Epilepsy Behav 2003; 4: 522–36.
99. Gonzalez LM, et al. The localization and lateralization of memory deficits in children with temporal lobe epilepsy. Epilepsia 2007; 48: 124–32.
100. Rzezak P, et al. Frontal lobe dysfunction in children with temporal lobe epilepsy. Pediatr Neurol 2007; 37: 176–85.
101. Wirrell EC, et al. Long-term psychosocial outcome in typical absence epilepsy. Sometimes a wolf in sheep's clothing. Arch Pediatr Adolesc Med 1997; 151: 152–8.
102. Berg AT, et al. Longitudinal assessment of adaptive behavior in infants and young children with newly diagnosed epilepsy: influences of etiology, syndrome, and seizure-control. Pediatrics 2004; 114: 645–50.
103. Oguni H, et al. Treatment and long-term prognosis of myoclonic-astatic epilepsy of early childhood. Neuropediatrics 2002; 33: 122–32.
104. Nickels K, Wirrell E. Electrical status epilepticus in sleep. Semin Pediatr Neurol 2008; 15: 50–60.
105. Kokkonen J, et al. Psychosocial outcome of young adults with epilepsy in childhood. J Neurol Neurosurg Psychiatry 1997; 62: 265–8.
106. Jalava M, et al. Social adjustment and competence 35 years after onset of childhood epilepsy: a prospective controlled study. Epilepsia 1997; 38: 708–15.
107. Camfield C, et al. Biologic factors as predictors of social outcome of epilepsy in intellectually normal children: a population-based study. J Pediatr 1993; 122: 869–73.
108. Loiseau P, et al. Long-term prognosis in two forms of childhood epilepsy: typical absence seizures and epilepsy with rolandic (centrotemporal) EEG foci. Ann Neurol 1983; 13: 642–8.
109. Camfield C, Camfield P. Twenty years after childhood-onset symptomatic generalized epilepsy the social outcome is usually dependency or death: a population-based study. Dev Med Child Neurol 2008; 50: 859–63.